Covalently PD‐L1 Anchoring Drives Bispecific Nanostructure Assembly for Spatial Control of T Cell Recruitment and Activation
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.5894316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Fengzhen Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention, College of Pharmacy, Ministry of Education, C…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Nanostructures, T-Lymphocytes. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Chongqing Natural Science Foundation.
Abstract (Originalsprache)
Immune checkpoint blockades have shown great potential in cancer therapy. However, achieving efficient recruitment and activation of T cells while blocking immune suppression remains a critical challenge. Current strategies mainly focus on the blockade of the PD‐1/PD‐L1 axis, with limited attention to reprogramming immune functions on the tumor cell surface. Here, we report a “localized oxidation‐covalent assembly” strategy that achieves precise modification of PD‐L1 on the cell surface through glycan oxidation, thereby harnessing bioorthogonal reactions to induce the in situ construction of artificial topological nanostructures (ATNs), which subsequently augment T cell‐mediated antitumor immunity. ATNs not only block the PD‐1/PD‐L1 axis to relieve immune suppression but also recruit and activate T cells through transmembrane bridging interactions, mimicking bispecific T cell engagers (BiTEs) and markedly enhancing antitumor immune responses. Mechanistic studies revealed that N‐glycosylation sites are critical for probe‐mediated aldehyde modification of PD‐L1. We further demonstrated that the ATNs achieve spatially precise T cell recruitment and activation via PD‐L1‐dependent localization, enabling programmable immune regulation. Overall, this approach not only underscores the potential of glycan oxidation‐driven self‐assembly in immune modulation but also provides a versatile chemical biology tool for the precise reprogramming of immune checkpoint functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention, College of Pharmacy, Ministry of Education, Chongqing Medical University, Chongqing, China.
- Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China.
ORCID-Profile: Jianli Zuo, Yongjun Dang, Xiaobo Wang, Hongwen Liang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Chongqing Natural Science Foundation
- Scientific and Technological Research Program of Chongqing Municipal Education Commission
- BAYU Scholar Program
- Chongqing Medical University
Zitieren
APA
Zhang, F., Dong, Y., Liu, K., Hu, H., Chang, H., Zuo, J., Ma, X., Xu, J., Dang, Y., Wang, X., & Liang, H. (2026). Covalently PD‐L1 Anchoring Drives Bispecific Nanostructure Assembly for Spatial Control of T Cell Recruitment and Activation. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.5894316
Vancouver
Zhang F, Dong Y, Liu K, Hu H, Chang H, Zuo J, et al. Covalently PD‐L1 Anchoring Drives Bispecific Nanostructure Assembly for Spatial Control of T Cell Recruitment and Activation. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.5894316
BibTeX
@article{Zhang2026,
author = {Zhang, Fengzhen and Dong, Yuhan and Liu, Kailu and Hu, Hui and Chang, Huimin and Zuo, Jianli and Ma, Xuedan and Xu, Jie and Dang, Yongjun and Wang, Xiaobo and Liang, Hongwen},
title = {Covalently PD‐L1 Anchoring Drives Bispecific Nanostructure Assembly for Spatial Control of T Cell Recruitment and Activation},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.5894316}
}
EUVIMED